Dr. Martens PLC (DOCS)

Currency in GBP
52.80
-1.30(-2.40%)
Closed·
Trading near 52-week Low
High dividend Yield
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.0055.00
52 wk Range
51.0090.00
Key Statistics
Bid/Ask
49.95 / 57.80
Prev. Close
54.1
Open
55
Day's Range
51-55
52 wk Range
51-90
Volume
8.79M
Average Vol. (3m)
1.47M
1-Year Change
-38.4257%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DOCS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
89.67
Upside
+69.82%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Dr. Martens PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 89.67
(+69.82% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold0.57+7.95%0.65MaintainNov 13, 2026
Barclays
Sell0.60+13.64%0.75DowngradeNov 02, 2026
Barclays
Hold0.75+42.05%0.85MaintainSep 10, 2026
Berenberg
Buy1.10+108.33%1.14MaintainMay 20, 2026
Barclays
Hold0.85+60.98%0.90MaintainNov 21, 2025

Dr. Martens PLC Earnings Call Summary for H1/2027

  • H1 FY2027 revenue fell 9.2% to £292.4M; adjusted EBIT swung to £2.2M loss from £3.1M profit as boots sales plunged 20%.
  • Gross margin improved 80bps to 65.4% aided by pricing discipline; net debt-to-EBITDA at 2.2x within covenant limits.
  • Stock plummeted 16.75% to $52.78, near 52-week low, as investors reacted to revenue decline and continued boots category weakness.
  • No specific FY guidance given; management expects H2-weighted results with new brand platform, e-commerce site, and sandals launch.
  • CEO cited hot European weather as key headwind; maintains medium-term targets of mid-to-high teens EBIT margin and profitable growth.
Last Updated: 11/12/2026, 05:34 AM
Read Full Transcript
Dr. Martens investor slides for H1/2027
Dr. Martens H1 FY27 slides
Last Update: Nov 12, 2026
See full investor slides

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.01 / -0.01
Revenue / Forecast
290.4M / 309M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.029
Dividend Yield
4.71%
Industry Median 2.36%
Annualized Payout
2.55
Paid unevenly
5-Years Growth
+15.89%
Growth Streak

DOCS Income Statement

Compare DOCS to Peers and Sector

Metrics to compare
DOCS
Peers
Sector
Relationship
P/E Ratio
18.1x17.5x9.5x
PEG Ratio
0.220.040.02
Price / Book
1.5x2.0x1.4x
Price / LTM Sales
0.7x0.7x0.8x
Upside (Analyst Target)
69.8%14.7%28.7%
Fair Value Upside
Unlock15.8%13.3%Unlock

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
331.38M34.86%174.97M
Other Institutional Investors
659.50M65.14%348.22M
Public Companies & Retail Investors
0.000.00%0.00
Total
990.88M100.00%523.18M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Permira Advisers Ltd.38.92%369,942,440195,330
Artemis Investment Management LLP12.85%122,166,09664,504

People Also Watch

191.80
QLT
-0.52%
148.60
BNKR
-1.72%
433.80
BYIT
-3.39%
425.00
SOI
-0.93%
652.00
LRE
+0.85%

FAQ

What Is the Dr. Martens (DOCS) Stock Price Today?

The Dr. Martens stock price today is 52.80 GBP.

What Stock Exchange Does Dr. Martens Trade On?

Dr. Martens is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Dr. Martens?

The stock symbol for Dr. Martens is "DOCS."

Does Dr. Martens Pay Dividends? What’s The Current Dividend Yield?

The Dr. Martens dividend yield is 4.7%%.

What Is the Dr. Martens Market Cap?

As of today, Dr. Martens market cap is 501.87M GBP.

What Is Dr. Martens's Earnings Per Share (TTM)?

The Dr. Martens EPS (TTM) is 0.029.

When Is the Next Dr. Martens Earnings Date?

Dr. Martens will release its next earnings report on Jun 03, 2027.

From a Technical Analysis Perspective, Is DOCS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dr. Martens Stock Split?

Dr. Martens has split 0 times.

How Many Employees Does Dr. Martens Have?

Dr. Martens has 3600 employees.

What is the current trading status of Dr. Martens (DOCS)?

As of Nov 15, 2026, Dr. Martens (DOCS) is trading at a price of 52.80 GBP, with a previous close of 54.10 GBP. The stock has fluctuated within a day range of 51.00 GBP to 55.00 GBP, while its 52-week range spans from 51.00 GBP to 90.00 GBP.

What Is Dr. Martens (DOCS) Price Target According to Analysts?

The average 12-month price target for Dr. Martens is 89.67 GBP, with a high estimate of 141 GBP and a low estimate of 57 GBP. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +69.82% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.